Solid Biosciences Inc reports results for the quarter ended in December - Earnings Summary

Solid Biosciences

23/03/2023 12:42

* Solid Biosciences Inc  SLDB.OQ  reported a quarterly
adjusted
loss of 68 cents​​ per share for the quarter ended in December.
The mean expectation of five analysts for the quarter was for a
loss of $1.65 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Solid Biosciences Inc's reported EPS for the quarter was a
loss
of 68 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Solid Biosciences Inc shares had fallen by 29.7% this
quarter.
    * The company reported a quarterly loss of $15.15 million.
    * Wall Street's median 12-month price target for Solid
Biosciences
Inc is $7.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 23 at 12:42 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -1.65          -0.68          Beat
 Sep. 30 2022      -2.67          -2.71          Missed
 Jun. 30 2022      -3.15          -3.30          Missed
 Mar. 31 2022      -2.76          -3.30          Missed